EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC 4.0

Clinical effectiveness and prospects of methylene blue: A systematic review

Assel Seitkazina, Jin-Kyoung Yang, Sehoon Kim

Precision and Future Medicine · 31.12.2022 · 6 (4) · 193-208

DOI: 10.23838/pfm.2022.00079 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Precision and Future Medicine, erschienen am 31.12.2022. Verfasst von Assel Seitkazina und 2 weiteren Autor:innen. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korea Health Industry Development Institute, National Research Foundation of Korea, Korea Institute of Science and Technology.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Methylene blue (MB) is a well-known pharmaceutical ingredient that is thought to have a multi-targeted therapeutic effect as an anti-malarial and neuroprotective agent and has recently been identified as a treatment for coronavirus disease 2019 (COVID-19). In this review, we present an overview of relevant clinical trials, including ongoing trials, on the therapeutic uses of MB. A search for clinical trials on clinicaltrials.gov was performed using the terms “methylene blue” and “methylthionine chloride.” This review focuses on clinical trials of MB-based therapies applied to brain diseases, cancer imaging and diagnosis, infectious diseases such as malaria or COVID-19, and cardiovascular diseases. Nanoparticle-based delivery techniques have also been briefly discussed in addition to common delivery methods.

Förderung

  • Korea Health Industry Development Institute
  • National Research Foundation of Korea
  • Korea Institute of Science and Technology

Zitieren

APA

Seitkazina, A., Yang, J., & Kim, S. (2022). Clinical effectiveness and prospects of methylene blue: A systematic review. Precision and Future Medicine, 6(4), 193-208. https://doi.org/10.23838/pfm.2022.00079

Vancouver

Seitkazina A, Yang J, Kim S. Clinical effectiveness and prospects of methylene blue: A systematic review. Precision and Future Medicine. 2022;6(4):193-208. doi:10.23838/pfm.2022.00079

BibTeX
@article{Seitkazina2022,
  author = {Seitkazina, Assel and Yang, Jin-Kyoung and Kim, Sehoon},
  title = {Clinical effectiveness and prospects of methylene blue: A systematic review},
  journal = {Precision and Future Medicine},
  year = {2022},
  volume = {6},
  number = {4},
  pages = {193--208},
  doi = {10.23838/pfm.2022.00079}
}
Kostenlos starten →